These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18370238)

  • 1. From SNPs to functional studies in cardiovascular pharmacogenomics.
    Cresci S
    Methods Mol Biol; 2008; 448():379-93. PubMed ID: 18370238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics in cardiovascular disease: the role of single nucleotide polymorphisms in improving drug therapy.
    Mango R; Vecchione L; Raso B; Borgiani P; Brunetti E; Mehta JL; Lauro R; Romeo F; Novelli G
    Expert Opin Pharmacother; 2005 Dec; 6(15):2565-76. PubMed ID: 16316297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics and cardiovascular drugs: need for integrated biological system with phenotypes and proteomic markers.
    Siest G; Marteau JB; Maumus S; Berrahmoune H; Jeannesson E; Samara A; Batt AM; Visvikis-Siest S
    Eur J Pharmacol; 2005 Dec; 527(1-3):1-22. PubMed ID: 16316654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics: the genetics of variable drug responses.
    Roden DM; Wilke RA; Kroemer HK; Stein CM
    Circulation; 2011 Apr; 123(15):1661-70. PubMed ID: 21502584
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic relevance of pharmacogenetic factors in cardiovascular medicine.
    Nakagawa K; Ishizaki T
    Pharmacol Ther; 2000 Apr; 86(1):1-28. PubMed ID: 10760544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Update on the genetics of stroke].
    López Fernández JC; Rodríguez Esparragón F; Buset Ríos N
    Med Clin (Barc); 2014 Aug; 143(4):176-9. PubMed ID: 24703417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular pharmacogenomics and individualized drug therapy.
    Pereira NL; Weinshilboum RM
    Nat Rev Cardiol; 2009 Oct; 6(10):632-8. PubMed ID: 19707183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacogenetics--new perspectives in the treatment of cardiovascular diseases].
    Dzida G
    Kardiol Pol; 2004 Mar; 60(3):304-8. PubMed ID: 15156230
    [No Abstract]   [Full Text] [Related]  

  • 9. The PPAR genes, cardiovascular disease and the emergence of PPAR pharmacogenetics.
    Cresci S
    Expert Opin Pharmacother; 2005 Dec; 6(15):2577-91. PubMed ID: 16316298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of microarrays and biochips in pharmacogenomics.
    Hardiman G
    Methods Mol Biol; 2008; 448():21-30. PubMed ID: 18370228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomics and management of cardiovascular disease.
    Howe LA
    Nurse Pract; 2009 Aug; 34(8):28-35; quiz 36. PubMed ID: 19638892
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacogenomics to Revive Drug Development in Cardiovascular Disease.
    Dubé MP; de Denus S; Tardif JC
    Cardiovasc Drugs Ther; 2016 Feb; 30(1):59-64. PubMed ID: 26768480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics, pharmacogenomics, and cardiovascular therapeutics: the way forward.
    Terra SG; Johnson JA
    Am J Cardiovasc Drugs; 2002; 2(5):287-96. PubMed ID: 14727958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomics and the prospects of existing and emerging therapeutics for cardiovascular diseases.
    Zaiou M; Benachour H; Marteau JB; Visvikis-Siest S; Siest G
    Curr Pharm Des; 2009; 15(27):3193-206. PubMed ID: 19754391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions.
    Nebert DW; Zhang G; Vesell ES
    Drug Metab Rev; 2008; 40(2):187-224. PubMed ID: 18464043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular pharmacogenetics.
    Myburgh R; Hochfeld WE; Dodgen TM; Ker J; Pepper MS
    Pharmacol Ther; 2012 Mar; 133(3):280-90. PubMed ID: 22123178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics in drug discovery and development. Preface.
    Yan Q
    Methods Mol Biol; 2008; 448():v-vii. PubMed ID: 18453067
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacogenetics and cardiovascular disease: impact on drug response and applications to disease management.
    Humma LM; Terra SG
    Am J Health Syst Pharm; 2002 Jul; 59(13):1241-52. PubMed ID: 12116890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular drugs and the genetic response.
    Dandona S
    Methodist Debakey Cardiovasc J; 2014; 10(1):13-7. PubMed ID: 24932357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The integration of personalized and systems medicine: bioinformatics support for pharmacogenomics and drug discovery.
    Yan Q
    Methods Mol Biol; 2008; 448():1-19. PubMed ID: 18370227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.